HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 - HUTCHMED (China) (NASDAQ:HCM)

HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 - HUTCHMED (China) (NASDAQ:HCM)

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED including savolitinib, fruquintinib and surufatinib, which will be presented at the upcoming American Association of Cancer Research (AACR) Annual Meeting 2025, taking place on April 25-30, 2025 in Chic…

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

Real-World Data in 100,000 Patients Further Support the Galleri® Test's Ability to Simultaneously Screen for Multiple Cancers, as Well as its Accuracy of Cancer Signal of Origin Prediction to Support More Efficient Diagnostic Evaluations

AACR 2025: Professional Awards Acknowledge Contributions to Cancer Research and Treatment

Ahead of this year’s meeting of the American Association for Cancer Research (AACR), the organization has released the names of the recipients of several professional awards that are given out annually. These awards recognize outstanding accomplishments and achievements in cancer research, therapy development, education, mentorship, and more. Most of the honorees, listed below, will give lectures during this year’s meeting, which is being held i…

Science at AACR Aims to Overcome Cancer Care Barriers

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for Cancer Research annual meeting runs April 25-30, with the key presentations coming Sunday through Tuesday.

#HUTCHMED Unveils Promising Cancer Therapeutics at AACR 2025,

'HUTCHMED to Showcase Groundbreaking Data at AACR Annual Meeting 2025' HONG KONG, SHANGHAI, and FLORHAM PARK, N.J. April 24, 2025 '' HUTCHMED (China) Limited, a biopharmaceutical company specializing in the development of innovative cancer therapies, has announced plans to present new and updated data from its research portfolio at the upcoming American Association of Cancer Research (AACR) Annual Meeting 2025. This key event is scheduled to tak…

HUTCHMED Highlights Data to be Presented at AACRAnnualMeeting2025

April 23, 2025 20:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED including savolitinib, fruquintinib and surufatinib, which will be presented at […]